USAIC Panel 2024: BioPharma Industry & Investment Outlook

Поделиться
HTML-код
  • Опубликовано: 21 ноя 2024
  • BioPharma Industry & Investment Outlook 2024
    Panelists:
    Christopher Viehbacher, President & CEO, Biogen
    Dilip Shanghvi, Founder & Managing Director, Sun Pharmaceutical Industries
    Hari Bhartia, Founder and Co-Chairman, Jubilant Bhartia Group
    Rajiv Kaul, Sector Portfolio Manager, Fidelity Investments
    Dr. Stelios Papadopoulos, Chairman of the Board, Exelixis
    Moderator:
    Daphne Zohar, Founder & Chief Executive Officer, Seaport Therapeutics

Комментарии •